1.33
-3.79(-74.02%)
Currency In USD
Address
505 Coast Boulevard South
La Jolla, CA 92037
United States of America
Phone
858-952-5500
Website
Sector
Healthcare
Industry
Biotechnology
Employees
14
First IPO Date
June 14, 2023
| Name | Title | Pay | Year Born |
| A. Rachel Leheny | Chief Executive Officer & Director | 416,944 | 1963 |
| Eric W. Roberts | Chief Business Officer & Vice Chairman of the Board | 390,600 | 1964 |
| Sudarshan Hebbar | Chief Medical Officer | 424,904 | 1965 |
| Kenneth A. Stauderman | Co-Founder & Chief Scientific Officer | 615,594 | 1953 |
| Anjana Rao | Co-Founder and Scientific Advisor | 0 | N/A |
| Patrick Hogan | Co-Founder and Scientific Advisor | 0 | N/A |
| Stefan Feske | Co-Founder and Scientific Advisor | 0 | N/A |
| John Dunn | General Counsel | 0 | 1952 |
| Michael J. Dunn | President & Chief Operating Officer | 0 | 1956 |
| Stephen Bardin | Chief Financial Officer | 0 | 1991 |
CalciMedica, Inc., a clinical-stage biotechnology company, focuses on developing therapies for life-threatening inflammatory diseases with unmet needs. Its proprietary technology targets the inhibition of calcium release-activated (CRAC) channels designs to modulate the immune response and protect against tissue cell injury in life-threatening inflammatory diseases. Its lead product candidate is Auxora, a proprietary intravenous-formulated CRAC channel inhibitor for the treatment of acute pancreatitis, asparaginase-associated acute pancreatitis, and acute kidney injury. The company is based in La Jolla, California.